Brief: Mereo Biopharma Provides Update On Pipeline Progress And Corporate Developments
08/01/2024 14:14
Jan 8 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA PROVIDES UPDATE ON PIPELINE PROGRESS AND
CORPORATE DEVELOPMENTS
* MEREO BIOPHARMA GROUP PLC- REITERATES PREVIOUS CASH RUNWAY
GUIDANCE; CURRENT CASH EXPECTED TO FUND OPERATIONS INTO 2026
* MEREO BIOPHARMA GROUP PLC- SIGNS GLOBAL LICENSING DEAL FOR
DEVELOPMENT AND COMMERCIALIZATION OF LEFLUTROZOLE
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand